drugset / Trial / NCT06388642
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the concentration of afamelanotide in serum after the administration of afamelanotide in adolescent and adult EPP patients.
Timeline
- Start
- 2024-03-07
- Primary completion
- 2024-10-28
- Completion
- 2025-01-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Afamelanotide | Peptide | 16 mg | — |